Hansoh Pharmaceutical Group Company Limited
HNSPF
$5.20
$0.4910.40%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 400.04M | 401.97M | 449.18M | 453.07M | 387.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 400.04M | 401.97M | 449.18M | 453.07M | 387.28M |
| Cost of Revenue | 36.89M | 37.07M | 40.46M | 40.81M | 34.72M |
| Gross Profit | 363.15M | 364.91M | 408.72M | 412.26M | 352.57M |
| SG&A Expenses | 169.17M | 169.99M | 143.24M | 144.48M | 155.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.37M | -1.38M | 3.57M | 3.60M | 2.63M |
| Total Operating Expenses | 309.31M | 310.80M | 269.88M | 272.22M | 273.42M |
| Operating Income | 90.73M | 91.17M | 179.30M | 180.85M | 113.87M |
| Income Before Tax | 136.72M | 137.38M | 215.30M | 217.16M | 156.94M |
| Income Tax Expenses | 22.29M | 22.40M | 27.11M | 27.35M | 19.22M |
| Earnings from Continuing Operations | 114.43M | 114.98M | 188.19M | 189.82M | 137.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 114.43M | 114.98M | 188.19M | 189.82M | 137.71M |
| EBIT | 90.73M | 91.17M | 179.30M | 180.85M | 113.87M |
| EBITDA | 102.58M | 103.08M | 193.45M | 195.13M | 125.71M |
| EPS Basic | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 5.93B | 5.93B | 5.93B | 5.93B | 5.93B |
| Average Diluted Shares Outstanding | 5.95B | 5.95B | 5.95B | 5.95B | 6.10B |
| Dividend Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Payout Ratio | 112.88% | 112.88% | -- | -- | 32.79% |